A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

Regadenoson

(2010) Karly P. Garnock-Jones et al.   American Journal of Cardiovascular Drugs

Prevalence of CKD and Comorbid Illness in Elderly Patients in the United States: Results From the Kidney Early Evaluation Program (KEEP)

(2010) Lesley A. Stevens et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Chronic kidney disease in hypertension under specialist care: the I-DEMAND study

(2009) Giovanna Leoncini et al.   JOURNAL OF HYPERTENSION

Regadenoson: A New Myocardial Stress Agent

(2009) Wael Al Jaroudi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications

(2008) Y Zhang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging

(2008) Manuel D. Cerqueira et al.   JACC-Cardiovascular Imaging